Extraction form for project: IPMP (Integrated Pain Management Programs)

Design Details

1. What type of program does the study assess (IPMP or CPMP)?
Integrated Pain Management Program (IPMP): Based in, integrated with, coordinated by primary care. Comprehensive Pain Management Program (CPMP): Referral based and separate from primary care.
2. In what country was the study conducted?
List all applicable countries.
3. What study design was used?
Please select the appropriate study design for the study. If the study design is not listed, you may add the appropriate study design.
4. Mean age
Report across all patients included in relevant study arms. Round to whole number. Include the word "years" after reporting the mean age.
5. % male
Report across all patients included in relevant study arms. Round to whole number. Include "%" symbol.
6. % Non-white
Report across all patients included in relevant study arms. Round to whole number. Include "%" symbol. If not reported, put NR.
7. Mean duration of pain or symptoms
Report across all patients included in relevant study arms. Round to whole number. Report duration in terms of months. If not reported, put NR.
8. Pain etiology/type
9. Disability
Disability can be measured in several ways. For example, authors may report the percent of patients receiving disability payments or they may report the mean score of a continuous disability scale such as the Pain Disability Index. Either are appropriate here, just be explicit about what is being reported.
10. Comorbidities
Extract the percent of patients with relevant comorbidities. Round percentages to whole numbers. If not reported, put NR.
% Depression diagnosis
% Anxiety diagnosis
% PTSD disagnosis
% Overweight or obese
% w/ Substance Use Disorder
% Smokers
% Suicidal
11. Randomized, Analyzed, and Attrition (at longest followup point)
For attrition report as: % (n/N)
Randomized
Analyzed
Attrition
12. How was the study funded?
13. Notes and comments

Arms

Arm NameArm Description
CPMP - "Exposure in vivo"Multidisciplinary rehabilitation using an "exposure in vivo" treatment approach
CPMP - graded activityMultidisciplinary rehabilitation using an operant graded activity treatment approach

Arm Details

1. Is the program practice-based or system-based?
CPMP - "Exposure in vivo"
CPMP - graded activity
2. How many patients were randomized to this treatment arm?
CPMP - "Exposure in vivo"
CPMP - graded activity
3. Program duration (weeks)
Please report the duration of the program in weeks and include "weeks" in the text box.
CPMP - "Exposure in vivo"
CPMP - graded activity
4. Number of sessions per week
Report as X sessions/week
CPMP - "Exposure in vivo"
CPMP - graded activity
5. Was the program conducted in the inpatient or outpatient setting?
Select one.
CPMP - "Exposure in vivo"
CPMP - graded activity
6. Physical Functioning/Reconditioning & Psychological and Mental Health Components of Intervention
For treatment providers, you may write-in any options that are needed that are not already presented. For duration of treatment report as "X sessions per week over X weeks", when possible. For anything not reported, put NR.
CPMP - "Exposure in vivo"
Physical Functioning/Reconditioning Components of InterventionPsychological and Mental Health Components of Intervention
Treatment types
Treatment providers
Mode of delivery
Duration of treatment
Tailoring
Adherence
CPMP - graded activity
Physical Functioning/Reconditioning Components of InterventionPsychological and Mental Health Components of Intervention
Treatment types
Treatment providers
Mode of delivery
Duration of treatment
Tailoring
Adherence
7. Medication Review and/or Management Components of Intervention
CPMP - "Exposure in vivo"
CPMP - graded activity
8. Additional components of the intervention
CPMP - "Exposure in vivo"
CPMP - graded activity
9. Description of care coordination/collaboration
CPMP - "Exposure in vivo"
CPMP - graded activity

Sample Characteristics

N/A

Outcomes

TypeDomainSpecific measurement (i.e., tool/definition/specific outcome)PopulationsTimepoints
ContinuousPainMcGill Pain Questionnaire
  • All Participants
  • Baseline
  • Post-intervention
  • 6 months
ContinuousPainQuebec Back Pain Disability scale
  • All Participants
  • Baseline
  • Post-intervention
  • 6 months
ContinuousFunctionRoland Morris Disability Questionnaire
  • All Participants
  • Baseline
  • Post-intervention
  • 6 months
ContinuousFunctionProportion of patients reporting clinically relevant changes on the RMDQ
  • All Participants
  • Baseline
  • Post-intervention
  • 6 months
ContinuousQOLPain catastrophizing scale main complains
  • All Participants
  • Baseline
  • Post-intervention
  • 6 months
ContinuousQOLProportion of patients reporting clinically relevant changes on the Pain catastrophizing scale
  • All Participants
  • Baseline
  • Post-intervention
  • 6 months
CategoricalProgram-Related OutcomesAdverse events/harms
  • All Participants
  • Baseline

Outcome Details

N/A

Risk of Bias Assessment

1. Randomization adequate?
Rating
2. Allocation concealment adequate?
Rating
3. Groups similar at baseline?
Rating
4. Outcome assessors masked?
Rating
5. Care providers masked?
Rating
6. Patient masked?
Rating
7. Reporting of attrition, crossovers, adherence, and contamination?
Rating
8. Loss to followup acceptable?
Overall ≤20%?
Difference between groups <10%?
9. Intention-to-treat (ITT) analysis?
Overall ≤20%?
10. Outcomes prespecified?
Overall ≤20%?
11. Quality determination
Overall ≤20%?

Results

Categorical


Program-Related Outcomes (Adverse events/harms)

All Participants
Descriptive StatisticsBetween Arm Comparisons
CPMP - "Exposure in vivo"CPMP - graded activity
Baseline
Total (N analyzed)
Odds Ratio (OR)
Events
95% CI low (OR)
Percentage
95% CI high (OR)
p value
Within Arm ComparisonsNet Comparisons
CPMP - "Exposure in vivo"CPMP - graded activity

Continuous


Pain (McGill Pain Questionnaire)

All Participants
Descriptive StatisticsBetween Arm Comparisons
CPMP - "Exposure in vivo"CPMP - graded activity
All Arms (ANOVA)
Baseline
Proportion
RR
Total (N analyzed)
95% CI low (RR)
Mean
95% CI high (RR)
SD
Mean Difference (MD)
SD
95% CI low (MD)
95% CI high (MD)
SD (MD)
p value (MD)
Post-intervention
Proportion
RR
Total (N analyzed)
95% CI low (RR)
Mean
95% CI high (RR)
SD
Mean Difference (MD)
SD
95% CI low (MD)
95% CI high (MD)
SD (MD)
p value (MD)
6 months
Proportion
RR
Total (N analyzed)
95% CI low (RR)
Mean
95% CI high (RR)
SD
Mean Difference (MD)
SD
95% CI low (MD)
95% CI high (MD)
SD (MD)
p value (MD)
Within Arm ComparisonsNet Comparisons
CPMP - "Exposure in vivo"CPMP - graded activity
All Arms (ANOVA)

Pain (Quebec Back Pain Disability scale )

All Participants
Descriptive StatisticsBetween Arm Comparisons
CPMP - "Exposure in vivo"CPMP - graded activity
All Arms (ANOVA)
Baseline
Proportion
RR
Total (N analyzed)
95% CI low (RR)
Mean
95% CI high (RR)
SD
Mean Difference (MD)
SD
95% CI low (MD)
95% CI high (MD)
SD (MD)
p value (MD)
Post-intervention
Proportion
RR
Total (N analyzed)
95% CI low (RR)
Mean
95% CI high (RR)
SD
Mean Difference (MD)
SD
95% CI low (MD)
95% CI high (MD)
SD (MD)
p value (MD)
6 months
Proportion
RR
Total (N analyzed)
95% CI low (RR)
Mean
95% CI high (RR)
SD
Mean Difference (MD)
SD
95% CI low (MD)
95% CI high (MD)
SD (MD)
p value (MD)
Within Arm ComparisonsNet Comparisons
CPMP - "Exposure in vivo"CPMP - graded activity
All Arms (ANOVA)

Function (Roland Morris Disability Questionnaire )

All Participants
Descriptive StatisticsBetween Arm Comparisons
CPMP - "Exposure in vivo"CPMP - graded activity
All Arms (ANOVA)
Baseline
Proportion
RR
Total (N analyzed)
95% CI low (RR)
Mean
95% CI high (RR)
SD
Mean Difference (MD)
SD
95% CI low (MD)
95% CI high (MD)
SD (MD)
p value (MD)
Post-intervention
Proportion
RR
Total (N analyzed)
95% CI low (RR)
Mean
95% CI high (RR)
SD
Mean Difference (MD)
SD
95% CI low (MD)
95% CI high (MD)
SD (MD)
p value (MD)
6 months
Proportion
RR
Total (N analyzed)
95% CI low (RR)
Mean
95% CI high (RR)
SD
Mean Difference (MD)
SD
95% CI low (MD)
95% CI high (MD)
SD (MD)
p value (MD)
Within Arm ComparisonsNet Comparisons
CPMP - "Exposure in vivo"CPMP - graded activity
All Arms (ANOVA)

Function (Proportion of patients reporting clinically relevant changes on the RMDQ)

All Participants
Descriptive StatisticsBetween Arm Comparisons
CPMP - "Exposure in vivo"CPMP - graded activity
All Arms (ANOVA)
Baseline
Proportion
RR
Total (N analyzed)
95% CI low (RR)
Mean
95% CI high (RR)
SD
Mean Difference (MD)
95% CI low (MD)
95% CI high (MD)
SD (MD)
p value (MD)
Post-intervention
Proportion
RR
Total (N analyzed)
95% CI low (RR)
Mean
95% CI high (RR)
SD
Mean Difference (MD)
95% CI low (MD)
95% CI high (MD)
SD (MD)
p value (MD)
6 months
Proportion
RR
Total (N analyzed)
95% CI low (RR)
Mean
95% CI high (RR)
SD
Mean Difference (MD)
95% CI low (MD)
95% CI high (MD)
SD (MD)
p value (MD)
Within Arm ComparisonsNet Comparisons
CPMP - "Exposure in vivo"CPMP - graded activity
All Arms (ANOVA)

QOL (Pain catastrophizing scale main complains)

All Participants
Descriptive StatisticsBetween Arm Comparisons
CPMP - "Exposure in vivo"CPMP - graded activity
All Arms (ANOVA)
Baseline
Proportion
RR
Total (N analyzed)
95% CI low (RR)
Mean
95% CI high (RR)
SD
Mean Difference (MD)
95% CI low (MD)
95% CI high (MD)
SD (MD)
p value (MD)
Post-intervention
Proportion
RR
Total (N analyzed)
95% CI low (RR)
Mean
95% CI high (RR)
SD
Mean Difference (MD)
95% CI low (MD)
95% CI high (MD)
SD (MD)
p value (MD)
6 months
Proportion
RR
Total (N analyzed)
95% CI low (RR)
Mean
95% CI high (RR)
SD
Mean Difference (MD)
95% CI low (MD)
95% CI high (MD)
SD (MD)
p value (MD)
Within Arm ComparisonsNet Comparisons
CPMP - "Exposure in vivo"CPMP - graded activity
All Arms (ANOVA)

QOL (Proportion of patients reporting clinically relevant changes on the Pain catastrophizing scale)

All Participants
Descriptive StatisticsBetween Arm Comparisons
CPMP - "Exposure in vivo"CPMP - graded activity
All Arms (ANOVA)
Baseline
Proportion
RR
Total (N analyzed)
95% CI low (RR)
95% CI high (RR)
Post-intervention
Proportion
RR
Total (N analyzed)
95% CI low (RR)
95% CI high (RR)
6 months
Proportion
RR
Total (N analyzed)
95% CI low (RR)
95% CI high (RR)
Within Arm ComparisonsNet Comparisons
CPMP - "Exposure in vivo"CPMP - graded activity
All Arms (ANOVA)